Strongbridge Biopharma plc·4

Feb 23, 5:16 PM ET

Wilhoit Scott L. 4

4 · Strongbridge Biopharma plc · Filed Feb 23, 2021

Insider Transaction Report

Form 4
Period: 2021-02-22
Wilhoit Scott L.
Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2021-02-22$3.62/sh7,121$25,778137,025 total
Footnotes (1)
  • [F1]Shares withheld by Strongbridge Biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -